Aardvark Therapeutics, Inc.
AARD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001774857
In the last 90 days, Aardvark Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $54.3M in total; no superinvestor holds it.
Holders of 5% or more of AARD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aardvark Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 13G | 18.30%3.92M shares | New | Feb 24, 20251 filing | Feb 24, 2025 | SEC |
| Lee Tien-Li | 13G | 13.70%2.98M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
| Tan Finian | 13G | 9.58%2.05M shares | New | Feb 24, 20251 filing | Feb 24, 2025 | SEC |
| Citadel Advisors LLC | 13G | 5.60%1.19M shares | New | Feb 24, 20251 filing | Feb 24, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Aardvark Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20254:52 PM ET | Lee Tien-Liand 1 other | 13G | 13.70%2.98M shares | New | Mar 31, 2025 | SEC |
| Feb 24, 20255:55 PM ET | Citadel Advisors LLCand 6 others | 13G | 5.60%1.19M shares | New | Feb 14, 2025 | SEC |
| Feb 24, 20254:16 PM ET | Decheng Capital Global Life Sciences Fund IV, L.P.and 4 others | 13G | 18.30%3.92M shares | New | Feb 14, 2025 | SEC |
| Feb 24, 20257:00 AM ET | Tan Finianand 2 others | 13G | 9.58%2.05M shares | New | Feb 12, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aardvark Therapeutics, Inc. shares.
No Form 144 notices for Aardvark Therapeutics, Inc. are on file.